Piper Jaffray maintained an Overweight rating on Marrone Bio Innovations (NASDAQ: MBII), and cut the price target to $1.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE